Clinical Trial Update: Study of BMS-663513 in Patients With Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports on BMS-663513 in patients with advanced cancer, noting that the Phase 1/2 study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-663513

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Tumors | Phase 1, Phase 2 | Status: TERMINATED